260
Participants
Start Date
January 11, 2024
Primary Completion Date
March 28, 2024
Study Completion Date
May 31, 2024
Oxaliplatin and capecitabine/ S-1 and capecitabine
Drug: capecitabine: 1000 mg/m² bid, po, d1-14, oxaliplatin: 130mg/m², iv drip for 2h, d1; S-1: BSA\<1.25m², 40mg bid, 1.25m²≤BSA≤1.5m², 50mg bid, BSA\>1.5m², 60mg bid, po, d1-14, oxaliplatin: 130mg/m², iv drip for 2h, d1
RECRUITING
Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital of Zhengzhou University
OTHER